Clinical Trial Update: Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

View source ↗

Summary

A completed AstraZeneca-sponsored clinical trial (NCT01635959) investigates the prevalence of gastroesophageal reflux disease (GERD) among patients presenting w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Patients With Upper Gastro-intestinal Symptoms | Status: COMPLETED